✦ LIBER ✦

Pharmacokinetics of Gepirone in Subjects with Normal Renal Function and in Patients with Chronic Renal Dysfunction

✍ Scribed by Dr Peter Dogterom, Jan A. M. Huisman, Ryszard Gellert, Aalt Verhagen

Book ID: 119929761
Publisher: Springer International Publishing AG
Year: 2002
Tongue: English
Weight: 149 KB
Volume: 22
Category: Article
ISSN: 1179-1918
DOI: 10.2165/00044011-200222080-00003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of naproxen in subjects

Pharmacokinetics of naproxen in subjects with normal and impaired renal function

✍ M. Anttila; M. Haataja; A. Kasanen 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 473 KB

Pharmacokinetics of sisomicin in normal

Pharmacokinetics of sisomicin in normal subjects and patients with renal failure

✍ G. Humbert; J. P. Fillastre; A. Leroy; G. Oksenhendler 📂 Article 📅 1979 🏛 Springer-Verlag 🌐 English ⚖ 238 KB

Pharmacokinetics of enalapril in normal

Pharmacokinetics of enalapril in normal subjects and patients with renal impairment.

✍ JG Kelly; G Doyle; J Donohue; M Laher; MJ Vandenburg; WJ Currie; WD Cooper 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 754 KB

Pharmacokinetics of cefadroxil in normal

Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency

✍ G. Humbert; A. Leroy; J. P. Fillastre; M. Godin 📂 Article 📅 1980 🏛 Springer-Verlag 🌐 English ⚖ 890 KB

Insulin Degludec has Similar Pharmacokin

Insulin Degludec has Similar Pharmacokinetic Properties in Subjects with Renal Impairment and Subjects with Normal Renal Function

✍ Kiss, István; Arold, Gerhard; Bøttcher, Susanne G.; Roepstorff, Carsten; Kapor, 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 51 KB

Pharmacokinetics of nicorandil in patien

Pharmacokinetics of nicorandil in patients with normal and impaired renal function

✍ M. Molinaro; G. Villa; M. B. Regazzi; A. Salvadeo; S. Segagni; R. Rondanelli; E. 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 489 KB

The pharmacokinetics of oral nicorandil 20 mg 12 hourly for 9 doses was evaluated in 21 hospitalized patients with angina pectoris due to coronary heart disease and with normal and impaired renal function. Patients were divided into 3 groups based on creatinine clearance (CLCr): GROUP I (n = 6) grea